KYFORA BIO, LLC – Trademark Portfolio
Entity Type: 16
KYFORA BIO, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 6 trademarks are registered and 4 are pending. Notable registered marks include MAXGENE, PEI MAX, KYFORA BIO, LIPOVECTOR, and TRANSPORTER 5. The owner is based in Horsham, PA.
767 Electronic Drive
Horsham, PA 19044
Showing of trademarks Trademarks
Trademark Classifications
KYFORA BIO, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does KYFORA BIO, LLC have?
KYFORA BIO, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 pending.
What trademark classes does KYFORA BIO, LLC file in?
KYFORA BIO, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are KYFORA BIO, LLC's most well-known trademarks?
KYFORA BIO, LLC's registered trademark portfolio includes well-known marks such as MAXGENE, PEI MAX, KYFORA BIO, LIPOVECTOR, and TRANSPORTER 5. These are among 6 currently registered trademarks in the portfolio.
What is KYFORA BIO, LLC's trademark registration success rate?
KYFORA BIO, LLC has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 4 applications are pending review.